Home
Scholarly Works
A RANDOMIZED PHASE II STUDY OF OGX-427 PLUS...
Conference

A RANDOMIZED PHASE II STUDY OF OGX-427 PLUS PREDNISONE (P) VS. P ALONE IN PATIENTS (PTS) WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (CRPC)

Authors

Chi K; Yu EY; Ellard S; Hotte SJ; Gingerich JR; Joshua AM; Gleave ME

Volume

23

Pagination

pp. 297-297

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2012

Name of conference

37th Congress of the European-Society-for-Medical-Oncology (ESMO)

Conference place

Vienna, AUSTRIA

Conference start date

September 28, 2012

Conference end date

October 2, 2012

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team